Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using machine learning to improve blood culture testing in emergency departments

Official title: Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning: a Randomized Controlled Trial

Run by Amsterdam UMC, location VUmc · NCT06163781 · Data updated 2026-11-12

This study is testing whether a new machine learning tool can help doctors in the emergency department decide when blood tests are really needed for adult patients, to see if it can reduce unnecessary tests while keeping patients safe.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment7584 (estimated)
SponsorAmsterdam UMC, location VUmc
Academic / other
Locations1 site (Amsterdam)
StatusRecruiting
StartedFebruary 19, 2024
Main results expectedJanuary 2027
Study endsJuly 2027
Registry record updatedMay 7, 2024
Trial IDNCT06163781 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who present to the emergency department with a clinical indication for blood culture analysis.

Probably not a fit

Patients with central venous lines, recent candidemia or S. aureus bacteremia, or those who are pregnant or breastfeeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a machine learning tool designed to predict the necessity of blood culture analyses in adult patients presenting to the emergency department. The study compares outcomes between patients who receive standard blood culture testing and those whose testing is guided by the prediction tool. Key outcomes include 30-day mortality, hospital admission rates, in-hospital mortality, and length of hospital stay. The goal is to determine if the tool can reduce unnecessary blood cultures while maintaining patient safety.

Why it matters

Potential benefit: If successful, this approach could lead to more efficient use of blood cultures, reducing unnecessary procedures and improving patient outcomes.

How similar studies have gone: Other studies have shown promise in using machine learning for clinical decision-making, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>= 18 years
* Have a clinical indication for a blood culture analysis (according to the treating physician)
* Have sufficient data recorded (laboratory results and vital sign measurements) for a prediction to be made (at least 20% of the needed parameters)

Exclusion Criteria:

* Central Venous Line (CVL) or Peripherally Inserted Central Catheter (PICC) in situ
* Neutrophil count \< 0.5 \* 109/L
* Candidemia or S. aureus bacteraemia in the past 3 months.
* Most likely diagnosis of endocarditis/spondylodiscitis/infected prosthetic material
* Pregnant or breastfeeding patients
* Not capable of giving informed consent

Where it's running

  • Amsterdam UMC - location AMC
    Amsterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.